Print

Millennium Pharmaceuticals, Inc. (South San Francisco, California) (MLNM) Becomes First Licensed Customer for BioClinica, Inc.’s New Enterprise Demand Aggregator  
3/30/2011 10:16:55 AM

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc., (NASDAQ: BIOC), a global provider of clinical trial management solutions, has signed a technology agreement with Millennium: The Takeda Oncology Company, (Millennium) a leading biopharmaceutical company. This agreement makes Millennium the first customer for BioClinica’s new Enterprise Demand Aggregator (“EDA”) product offering. As part of the agreement BioClinica and Millennium will work in partnership to speed the release of the product which will advance Millennium’s clinical trial supply planning across all their global clinical trials.
//-->